Mymd Pharmaceuticals, Inc. (NASDAQ:QCLS – Get Free Report) shares traded up 5.4% on Monday . Get Mymd Pharmaceuticals alerts:View Our Latest Stock Report on Mymd PharmaceuticalsMymd Pharmaceuticals Price PerformanceThe business’s fifty day moving average is $3.63. Mymd Pharmaceuticals (NASDAQ:QCLS – Get Free Report) last released its earnings results on Friday, May 15th. Mymd Pharmaceuticals Company Profile(Get Free Report)MyMD Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for immune-related and other serious diseases. See AlsoReceive News & Ratings for Mymd Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mymd Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.